Highlights
NASDAQ: APTX       Aptinyx Inc
Last Price Today's Change   Day's Range   Trading Volume
0.57   +0.012 (2.15%)  0.53 - 0.61  267,765

Overview

 
Avg Volume (4 weeks):322,359
4 Weeks Range:0.368 - 0.61
4 Weeks Price Volatility (%):
83.47%
52 Weeks Range:0.368 - 3.71
52 Weeks Price Volatility (%):
6.04%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5479  3307  1168  2358 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ALNA 0.241+0.05 
 ENDP 0.53+0.064 
 TQQQ 23.59-0.41 
 ISBC 13.87-0.35 
 DIDI 2.29-0.07 
 XELA 0.116+0.002 
 AMD 74.09-2.38 
 SQQQ 59.67+0.83 
 AKBA 0.39+0.037 
 QNRX 0.74+0.29